{"transactions":[{"id":1582771,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":93202,"kind":"person","name":"Phillips Geraint","position":1,"cik":"0001960665","reported_name":"Phillips Geraint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Operations"}}],"security":"Common Stock","published_at":"2024-03-13T01:44:08.000Z","date":"2024-03-12","kind":"sale","planned":true,"acquired":false,"shares":3598,"price":16.6,"value":59726.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":65998,"source":{"system":"sec-edgar","filing":"0001628280-24-010746","document":"wk-form4_1710294237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024010746/wk-form4_1710294237.xml","form_type":"4"}},{"id":1582770,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":93202,"kind":"person","name":"Phillips Geraint","position":1,"cik":"0001960665","reported_name":"Phillips Geraint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Operations"}}],"security":"Common Stock","published_at":"2024-03-13T01:44:08.000Z","date":"2024-03-11","kind":"sale","planned":true,"acquired":false,"shares":206,"price":17.42,"value":3588.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":69596,"source":{"system":"sec-edgar","filing":"0001628280-24-010746","document":"wk-form4_1710294237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024010746/wk-form4_1710294237.xml","form_type":"4"}},{"id":1582769,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":93202,"kind":"person","name":"Phillips Geraint","position":1,"cik":"0001960665","reported_name":"Phillips Geraint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Operations"}}],"security":"Common Stock","published_at":"2024-03-13T01:44:08.000Z","date":"2024-03-08","kind":"grant","planned":true,"acquired":true,"shares":11682,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the 2013 Performance Incentive Plan. In accordance with the terms of the grant, the restricted stock vested as to 125% of the reported number of shares reported in the reporting person's Form 4 reporting the grant based on the registrant's total shareholder return during the period beginning on January 1, 2022 through December 31, 2023 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date)."}],"balance_after":69802,"source":{"system":"sec-edgar","filing":"0001628280-24-010746","document":"wk-form4_1710294237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024010746/wk-form4_1710294237.xml","form_type":"4"}},{"id":1623691,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":93202,"kind":"person","name":"Phillips Geraint","position":1,"cik":"0001960665","reported_name":"Phillips Geraint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Operations"}}],"security":"Common Stock","published_at":"2024-02-23T22:51:41.000Z","date":"2024-02-21","kind":"sale","planned":true,"acquired":false,"shares":131,"price":17.35,"value":2272.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":58120,"source":{"system":"sec-edgar","filing":"0001628280-24-006708","document":"wk-form4_1708728687.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024006708/wk-form4_1708728687.xml","form_type":"4"}},{"id":1673596,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":93202,"kind":"person","name":"Phillips Geraint","position":1,"cik":"0001960665","reported_name":"Phillips Geraint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Operations"}}],"security":"Common Stock","published_at":"2024-01-23T22:30:21.000Z","date":"2024-01-19","kind":"sale","planned":true,"acquired":false,"shares":1776,"price":16.76,"value":29765.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":58251,"source":{"system":"sec-edgar","filing":"0001628280-24-001984","document":"wk-form4_1706049012.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828024001984/wk-form4_1706049012.xml","form_type":"4"}},{"id":1702761,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":93202,"kind":"person","name":"Phillips Geraint","position":1,"cik":"0001960665","reported_name":"Phillips Geraint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Operations"}}],"security":"Common Stock","published_at":"2023-12-21T20:44:21.000Z","date":"2023-12-03","kind":"grant","planned":false,"acquired":true,"shares":229,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant."}],"balance_after":60027,"source":{"system":"sec-edgar","filing":"0001628280-23-042479","document":"wk-form4_1703191454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023042479/wk-form4_1703191454.xml","form_type":"4"}},{"id":1705929,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":93202,"kind":"person","name":"Phillips Geraint","position":1,"cik":"0001960665","reported_name":"Phillips Geraint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Operations"}}],"security":"Common Stock","published_at":"2023-12-19T22:54:24.000Z","date":"2023-12-17","kind":"grant","planned":false,"acquired":true,"shares":211,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant."}],"balance_after":59798,"source":{"system":"sec-edgar","filing":"0001628280-23-042029","document":"wk-form4_1703026451.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023042029/wk-form4_1703026451.xml","form_type":"4"}},{"id":1724591,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":93202,"kind":"person","name":"Phillips Geraint","position":1,"cik":"0001960665","reported_name":"Phillips Geraint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Operations"}}],"security":"Common Stock","published_at":"2023-12-05T00:14:43.000Z","date":"2023-12-01","kind":"sale","planned":true,"acquired":false,"shares":303,"price":12.37,"value":3748.11,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":59587,"source":{"system":"sec-edgar","filing":"0001628280-23-040674","document":"wk-form4_1701735274.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023040674/wk-form4_1701735274.xml","form_type":"4"}},{"id":1724590,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":93202,"kind":"person","name":"Phillips Geraint","position":1,"cik":"0001960665","reported_name":"Phillips Geraint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Operations"}}],"security":"Common Stock","published_at":"2023-12-05T00:14:43.000Z","date":"2023-11-19","kind":"grant","planned":true,"acquired":true,"shares":234,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant."}],"balance_after":59890,"source":{"system":"sec-edgar","filing":"0001628280-23-040674","document":"wk-form4_1701735274.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023040674/wk-form4_1701735274.xml","form_type":"4"}},{"id":1741562,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":93202,"kind":"person","name":"Phillips Geraint","position":1,"cik":"0001960665","reported_name":"Phillips Geraint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Operations"}}],"security":"Common Stock","published_at":"2023-11-15T15:41:16.000Z","date":"2023-11-13","kind":"sale","planned":true,"acquired":false,"shares":111,"price":10.66,"value":1183.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":59656,"source":{"system":"sec-edgar","filing":"0001628280-23-039097","document":"wk-form4_1700062865.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023039097/wk-form4_1700062865.xml","form_type":"4"}},{"id":1745088,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":93202,"kind":"person","name":"Phillips Geraint","position":1,"cik":"0001960665","reported_name":"Phillips Geraint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Operations"}}],"security":"Common Stock","published_at":"2023-11-13T21:41:05.000Z","date":"2023-11-05","kind":"grant","planned":false,"acquired":true,"shares":262,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant."}],"balance_after":59767,"source":{"system":"sec-edgar","filing":"0001628280-23-038653","document":"wk-form4_1699911654.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023038653/wk-form4_1699911654.xml","form_type":"4"}},{"id":1755978,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":93202,"kind":"person","name":"Phillips Geraint","position":1,"cik":"0001960665","reported_name":"Phillips Geraint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Operations"}}],"security":"Common Stock","published_at":"2023-10-24T23:45:55.000Z","date":"2023-10-22","kind":"grant","planned":false,"acquired":true,"shares":291,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant."}],"balance_after":59505,"source":{"system":"sec-edgar","filing":"0001628280-23-035028","document":"wk-form4_1698191134.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023035028/wk-form4_1698191134.xml","form_type":"4"}},{"id":1763048,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":93202,"kind":"person","name":"Phillips Geraint","position":1,"cik":"0001960665","reported_name":"Phillips Geraint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Operations"}}],"security":"Common Stock","published_at":"2023-10-10T21:25:57.000Z","date":"2023-10-08","kind":"grant","planned":false,"acquired":true,"shares":219,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant."}],"balance_after":59214,"source":{"system":"sec-edgar","filing":"0001628280-23-034202","document":"wk-form4_1696973147.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023034202/wk-form4_1696973147.xml","form_type":"4"}},{"id":1771051,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":93202,"kind":"person","name":"Phillips Geraint","position":1,"cik":"0001960665","reported_name":"Phillips Geraint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Operations"}}],"security":"Common Stock","published_at":"2023-10-02T20:58:15.000Z","date":"2023-09-24","kind":"grant","planned":false,"acquired":true,"shares":221,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant."}],"balance_after":58995,"source":{"system":"sec-edgar","filing":"0001628280-23-033499","document":"wk-form4_1696280285.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023033499/wk-form4_1696280285.xml","form_type":"4"}},{"id":1783475,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":93202,"kind":"person","name":"Phillips Geraint","position":1,"cik":"0001960665","reported_name":"Phillips Geraint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Operations"}}],"security":"Common Stock","published_at":"2023-09-12T20:49:23.000Z","date":"2023-09-10","kind":"grant","planned":false,"acquired":true,"shares":328,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant."}],"balance_after":58774,"source":{"system":"sec-edgar","filing":"0001628280-23-032091","document":"wk-form4_1694551753.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023032091/wk-form4_1694551753.xml","form_type":"4"}},{"id":1793689,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":93202,"kind":"person","name":"Phillips Geraint","position":1,"cik":"0001960665","reported_name":"Phillips Geraint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Operations"}}],"security":"Common Stock","published_at":"2023-08-30T21:39:34.000Z","date":"2023-08-27","kind":"grant","planned":false,"acquired":true,"shares":401,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant."}],"balance_after":58446,"source":{"system":"sec-edgar","filing":"0001628280-23-031007","document":"wk-form4_1693431566.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023031007/wk-form4_1693431566.xml","form_type":"4"}},{"id":1794691,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":93202,"kind":"person","name":"Phillips Geraint","position":1,"cik":"0001960665","reported_name":"Phillips Geraint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Operations"}}],"security":"Common Stock","published_at":"2023-08-29T21:49:22.000Z","date":"2023-08-25","kind":"sale","planned":true,"acquired":false,"shares":179,"price":10.99,"value":1967.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":58045,"source":{"system":"sec-edgar","filing":"0001628280-23-030910","document":"wk-form4_1693345751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023030910/wk-form4_1693345751.xml","form_type":"4"}},{"id":1806713,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":93202,"kind":"person","name":"Phillips Geraint","position":1,"cik":"0001960665","reported_name":"Phillips Geraint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Operations"}}],"security":"Common Stock","published_at":"2023-08-16T20:47:42.000Z","date":"2023-08-14","kind":"sale","planned":true,"acquired":false,"shares":109,"price":12.57,"value":1370.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":58224,"source":{"system":"sec-edgar","filing":"0001628280-23-029684","document":"wk-form4_1692218854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000162828023029684/wk-form4_1692218854.xml","form_type":"4"}},{"id":1845865,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":93202,"kind":"person","name":"Phillips Geraint","position":1,"cik":"0001960665","reported_name":"Phillips Geraint","relationship":{"officer":true,"officer_title":"SVP, Global Operations"}}],"security":"Common Stock","published_at":"2023-06-23T23:34:31.000Z","date":"2023-02-21","kind":"sale","planned":true,"acquired":false,"shares":133,"price":21.47,"value":2855.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":59451,"source":{"system":"sec-edgar","filing":"0001437749-23-018322","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923018322/rdgdoc.xml","form_type":"4"}},{"id":1845864,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":93202,"kind":"person","name":"Phillips Geraint","position":1,"cik":"0001960665","reported_name":"Phillips Geraint","relationship":{"officer":true,"officer_title":"SVP, Global Operations"}}],"security":"Common Stock","published_at":"2023-06-23T23:33:04.000Z","date":"2023-03-01","kind":"sale","planned":true,"acquired":false,"shares":844,"price":22.75,"value":19201.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":58607,"source":{"system":"sec-edgar","filing":"0001437749-23-018321","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923018321/rdgdoc.xml","form_type":"4"}},{"id":1845863,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":93202,"kind":"person","name":"Phillips Geraint","position":1,"cik":"0001960665","reported_name":"Phillips Geraint","relationship":{"officer":true,"officer_title":"SVP, Global Operations"}}],"security":"Common Stock","published_at":"2023-06-23T23:31:50.000Z","date":"2023-05-16","kind":"sale","planned":true,"acquired":false,"shares":100,"price":19.41,"value":1941.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":58507,"source":{"system":"sec-edgar","filing":"0001437749-23-018320","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923018320/rdgdoc.xml","form_type":"4"}},{"id":1845862,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":93202,"kind":"person","name":"Phillips Geraint","position":1,"cik":"0001960665","reported_name":"Phillips Geraint","relationship":{"officer":true,"officer_title":"SVP, Global Operations"}}],"security":"Common Stock","published_at":"2023-06-23T23:30:56.000Z","date":"2023-05-31","kind":"sale","planned":true,"acquired":false,"shares":174,"price":23.21,"value":4038.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":58333,"source":{"system":"sec-edgar","filing":"0001437749-23-018319","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923018319/rdgdoc.xml","form_type":"4"}},{"id":2058064,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":93202,"kind":"person","name":"Phillips Geraint","position":1,"cik":"0001960665","reported_name":"Phillips Geraint","relationship":{"officer":true,"officer_title":"SVP, Global Operations"}}],"security":"Restricted Stock Award","published_at":"2023-01-11T00:01:10.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":21222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in Column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2023 through December 31, 2024 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in Column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2023 through December 31, 2024 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in Column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2023 through December 31, 2024 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period."}],"balance_after":21222,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":21222},"source":{"system":"sec-edgar","filing":"0001437749-23-000816","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923000816/rdgdoc.xml","form_type":"4"}},{"id":2058063,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":93202,"kind":"person","name":"Phillips Geraint","position":1,"cik":"0001960665","reported_name":"Phillips Geraint","relationship":{"officer":true,"officer_title":"SVP, Global Operations"}}],"security":"Common Stock","published_at":"2023-01-11T00:01:10.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":21222,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan (the \"Plan\") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2023 compensation."}],"balance_after":59584,"source":{"system":"sec-edgar","filing":"0001437749-23-000816","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774923000816/rdgdoc.xml","form_type":"4"}}]}